Fig. 1

Serum levels of inflammatory molecules at hospital admission in COVID-19 patients. HMGB1, NLRP3, ACE2, IL-6 levels were significantly increased in COVID-19 patients with headache (n = 48) compared to COVID-19 patients without headache (n = 40). Angiotensin II level was significantly decreased in COVID-19 patients with headache